AusPAR: Linagliptin / Metformin HCl
Australian Public Assessment Report
Device/Product Name
Trajentamet
Active ingredients
Linagliptin / Metformin HCl
AusPAR Date
Published
Sponsor
Submission Number
PM-2011-03536-3-5
Submission Type
New fixed combination
Decision
Approved